Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
Sacituzumab Govitecan + Toripalimab as First - Line Therapy for Advanced Triple - Negative Breast Cancer and Biomarker Exploration
ClinicalTrials.gov study NCT06991790. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase II Clinical Trial of PD-L1 in Combination with Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy with or Without Radiotherapy for Advanced Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06771609. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer
ClinicalTrials.gov study NCT05747313. IPD Sharing: NO. Countries: 1. Publications: 0.
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
ClinicalTrials.gov study NCT07276880. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC).
ClinicalTrials.gov study NCT03742349. IPD Sharing: NO. Countries: 9. Publications: 0.
Collecting, Analyzing, and Storing Samples From Patients With Metastatic, Triple Negative Breast Cancer Receiving Anti-cancer Therapy
ClinicalTrials.gov study NCT01957514. IPD Sharing: Not stated. Countries: 1. Publications: 0.
LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcom
ClinicalTrials.gov study NCT03449108. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT06367088. IPD Sharing: NO. Countries: 1. Publications: 0.
PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer
ClinicalTrials.gov study NCT07190469. IPD Sharing: NO. Countries: 2. Publications: 0.
Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT07311993. IPD Sharing: NO. Countries: 1. Publications: 0.
Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05019690. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05071677. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of SCT200 in Patients With Relapsed or Metastatic Triple Receptor Negative Breast Cancer
ClinicalTrials.gov study NCT03692689. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05088057. IPD Sharing: NO. Countries: 1. Publications: 0.
Prevention of Sacituzumab Govitecan-related Neutropenia in Patients With Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT06616987. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06604858. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in Advanced Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT06889688. IPD Sharing: NO. Countries: 1. Publications: 0.
BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based Chemotherapy
ClinicalTrials.gov study NCT01672671. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast Cancer
ClinicalTrials.gov study NCT01969032. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06798506. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.